Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03917641Unknown
Open-label trial of khat in edema and hematoma, sponsored by Sheba Medical Center. Primary endpoints: Edema at 7 days and Hematoma at 7 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03917641.